| HAdV-B7 | HAdV-B3 | ||
---|---|---|---|---|
Variables | Single infection | Coinfection | Single infection | Coinfection |
(n = 30) | (n = 52) | (n = 15) | (n = 27) | |
Age (years)a | 3.47 ± 3.08 | 1.20 ± 1.26 | 4.91 ± 4.63 | 2.62 ± 2.99 |
Male (%) | 19 (63.3 %) | 41 (56.2 %) | 9 (60.0 %) | 17 (63.0 %) |
Symptoms and signs | Â | Â | Â | Â |
Fever | 29 (96.7 %) | 51 (98.1 %) | 15 (100 %) | 24 (88.9 %) |
T max (°C) | 39.84 ± 0.71 | 39.50 ± 0.57 | 39.55 ± 0.53 | 39.78 ± 0.67 |
Duration of fever (days)b | 22.07 ± 21.52 | 14.02 ± 6.36 | 9.73 ± 7.31 | 15.38 ± 14.36 |
Cough | 30 (100 %) | 52 (100 %) | 15 (100 %) | 26 (96.3 %) |
Rhinorrhea | 4 (13.3 %) | 7 (13.5 %) | 3 (20 %) | 5 (18.5 %) |
Wheezing | 17 (56.7 %) | 37 (71.2 %) | 7 (46.7 %) | 13 (48.1 %) |
Swelling of tonsils | 11 (36.7 %) | 9 (17.3 %) | 7 (46.7 %) | 9 (33.3 %) |
Rash | 3 (10.0 %) | 5 (9.6 %) | 0 | 3 (11.1 %) |
Vomitting | 3 (10.0 %) | 5 (9.6 %) | 2 (13.3 %) | 3 (11.1 %) |
Diarrhea | 9 (30.0 %) | 13 (25.0 %) | 1 (6.7 %) | 7 (25.9 %) |
Conjunctivitis | 1 (3.3 %) | 3 (5.8 %) | 0 | 1 (3.7 %) |
Dyspnea | 13 (43.3 %) | 26 (50.0 %) | 4 (26.7 %) | 9 (33.3 %) |
ICU admission | 6 (20.0 %) | 7 (13.5 %) | 0 | 2 (7.4 %) |
Any underlying diseases | 5 (16.7 %) | 6 (11.5 %) | 4 (26.7 %) | 4 (14.8 %) |
Treatment | Â | Â | Â | Â |
Mechanical ventilation | 8 (26.7 %) | 19 (36.5%) | 4 (26.7 %) | 4 (14.8 %) |
Coticosteriods | 26 (86.7 %) | 45 (86.5%) | 12 (80.0 %) | 24 (88.9 %) |
Inhaled | 16 (53.3 %) | 29 (55.8%) | 5 (33.3 %) | 14 (51.9 %) |
Intravenous | Â | Â | Â | Â |
Immunoglobulinc | 8 (26.7 %) | 20 (38.5 %) | 0 | 4 (14.8 %) |
Length of hospital stay (days) | 18.50 ± 12.87 | 22.44 ± 11.67 | 12.33 ± 4.95 | 16.89 ± 10.88 |
Laboratory findings | Â | Â | Â | Â |
WBC (×109/L) | 8.75 ± 4.63 | 9.96 ± 4.95 | 10.34 ± 5.23 | 10.87 ± 3.91 |
CRP (mg/L) | 34.68 ± 42.70 | 33.95 ± 39.30 | 41.96 ± 36.84 | 31.54 ± 27.96 |
AST, median (IQR) (U/L)d | 67 (38.8–100) | 60 (38.3–94.3) | 33 (27–45) | 38 (26–51) |
ALT, median (IQR) (U/L)e | 20 (16–36) | 25 (19–42.8) | 15 (12–21) | 17 (13–26) |
LDH, median (IQR) (U/L)f | 565 (341.8–1232.8) | 470.5 (305.3–922.8) | 297 (207–397) | 311 (245–462) |
CK, median (IQR) (U/L) | 125.5 (48–499.8) | 87 (45.5–187.5) | 77 (46–99) | 6 (43–115) |
HBDH, median (IQR) (U/L)g | 408 (242.8–803) | 356.5 (225.9–647.5) | 219 (162–313) | 210 (199–374) |